Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 21, 2016 (10 years ago)

Chorionic Gonadotropin Lyophilized

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Chorionic Gonadotropin Lyophilized, 20,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

Recalling firm
Wells Pharmacy Network LLC
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0351-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Wells Pharmacy Network LLC

All 2016 recalls

Other sterility / contamination recalls from 2016

All sterility / contamination recalls
Class II · Moderate risk

AMGEN Kyprolis

Lack of Assurance of Sterility: Potential cracks in glass vials

Terminated Sterility / contamination Amgen, Inc. NDC 76075-102-01 D-0226-2017
Class I · High risk

Nano PNC Water

Marketed without an Approved NDA/ANDA and non-sterility: NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.

Terminated Sterility / contamination Pacific Medical Solutions D-0505-2017
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-6046-48 D-0206-2017